ADTX
Price
$2.30
Change
-$0.01 (-0.43%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
2.78M
XTLB
Price
$1.30
Change
+$0.08 (+6.56%)
Updated
Apr 24, 02:57 PM (EDT)
Capitalization
10.95M
Ad is loading...

ADTX vs XTLB

Header iconADTX vs XTLB Comparison
Open Charts ADTX vs XTLBBanner chart's image
Aditxt
Price$2.30
Change-$0.01 (-0.43%)
Volume$4K
Capitalization2.78M
XTL Biopharmaceuticals
Price$1.30
Change+$0.08 (+6.56%)
Volume$262
Capitalization10.95M
ADTX vs XTLB Comparison Chart
Loading...
ADTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADTX vs. XTLB commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADTX is a Hold and XTLB is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ADTX: $2.31 vs. XTLB: $1.22)
Brand notoriety: ADTX and XTLB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADTX: 3% vs. XTLB: 12%
Market capitalization -- ADTX: $2.78M vs. XTLB: $10.95M
ADTX [@Biotechnology] is valued at $2.78M. XTLB’s [@Biotechnology] market capitalization is $10.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADTX’s FA Score shows that 0 FA rating(s) are green whileXTLB’s FA Score has 0 green FA rating(s).

  • ADTX’s FA Score: 0 green, 5 red.
  • XTLB’s FA Score: 0 green, 5 red.
According to our system of comparison, XTLB is a better buy in the long-term than ADTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADTX’s TA Score shows that 3 TA indicator(s) are bullish.

  • ADTX’s TA Score: 3 bullish, 3 bearish.

Price Growth

ADTX (@Biotechnology) experienced а +5.00% price change this week, while XTLB (@Biotechnology) price change was +7.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

ADTX is expected to report earnings on Mar 31, 2025.

XTLB is expected to report earnings on Dec 03, 2024.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XTLB($11M) has a higher market cap than ADTX($2.78M). XTLB YTD gains are higher at: -40.024 vs. ADTX (-95.132). XTLB has higher annual earnings (EBITDA): 630K vs. ADTX (-29.74M). ADTX has more cash in the bank: 329K vs. XTLB (133K). ADTX has higher revenues than XTLB: ADTX (212K) vs XTLB (0).
ADTXXTLBADTX / XTLB
Capitalization2.78M11M25%
EBITDA-29.74M630K-4,720%
Gain YTD-95.132-40.024238%
P/E RatioN/AN/A-
Revenue212K0-
Total Cash329K133K247%
Total Debt10.1MN/A-
FUNDAMENTALS RATINGS
XTLB: Fundamental Ratings
XTLB
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADTX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 22 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ADTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OMSYX25.10N/A
N/A
Invesco Main Street All Cap Y
ANDVX9.47N/A
N/A
Virtus NFJ Dividend Value R6
VSFSX21.25N/A
N/A
Federated Hermes Clover Small Value R6
INGFX32.49N/A
N/A
Invesco Oppenheimer International Gr R5
TSGMX13.29N/A
N/A
Transamerica Sustainable Growth Eq R6

ADTX and

Correlation & Price change

A.I.dvisor tells us that ADTX and ORMP have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADTX and ORMP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADTX
1D Price
Change %
ADTX100%
N/A
ORMP - ADTX
32%
Poorly correlated
+0.66%
CSCI - ADTX
28%
Poorly correlated
+2.47%
XTLB - ADTX
27%
Poorly correlated
-7.25%
BDRX - ADTX
25%
Poorly correlated
+1.43%
APRE - ADTX
25%
Poorly correlated
-1.62%
More